Comparing the Efficacy Between Lignocaine Given Via MADgic Atomizer and Lignocaine Pump Spray

Universiti Sains Malaysia

Status: Completed

Conditions: Hemodynamic Instability; Hoarseness; Cough; Sore Throat

Treatments: Device: Lignocaine pump spray; Device: MADgic Atomizer

Study type: Interventional

Funder types: Other

Identifiers

NCT06213116

USM/JEPeM/21080580

Details and patient eligibility

About

Comparing the efficacy between Lignocaine given via MADgic Atomizer and Lignocaine Pump Spray pre endotracheal intubation in adult undergoing General Anesthesia.

Full description

Comparing the efficacy of Lignocaine given via 2 device (Lignocaine Spray and MADGIC Atomizer) on hemodinamic parameters postintubations and severity grading of post operative sore throat, cough and hoarseness of voice.

Enrollment: 125 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult with the age of 18 to 65 years old
• Gender of both male and female
• Planned for elective surgery scheduled at General Operation Theatre that require elective intubation for general anesthesia
• American Society Anaesthesiologist (ASA) preoperative physical status assessment of 1 and 2
• Airway assessment Malampati scoring 1and 2.

Exclusion criteria

• Pregnancy
• Known allergy or hypersensitivity to Lignocaine
• Pre existing sore throat or hoarseness of voice identified during preoperative assessment.
• The use of airway device other than endotracheal tube (ETT) such Laryngeal Mask airway/Supraglottic Device'
• Oral and neck surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

125 participants in 2 patient groups

MADgic Atomizer

Experimental group

Description:

Group M(MADgic) acting as Intervention Group: Patients receiving Lignocaine 30mg (3 alliquotes) given via MADgic Laryngotracheal Atomization Device prior to endotracheal intubation.

Treatment:

Device: MADgic Atomizer

Lignocaine Spray

Active Comparator group

Description:

Group S (Spray) acting as Control Group: Patients receiving Lignocaine 30 mg (3 puffs) given via 10mg Lignocain Pump Spray prior to endotracheal intubation.

Treatment:

Device: Lignocaine pump spray